The article "Biotech Companies Turn To Practical Pharmacogenomics," which appeared in the March 22 issue of BioWorld Financial Watch, neglected to mention one of the major pharmacogenomics collaborations that occurred in 1997. In July of that year, Genset SA and Abbott Laboratories signed a strategic alliance in pharmacogenomics valued at $42.5 million.